revolvo.tech
Trialmark — Clinical trial site oversight concept
A pharmaceutical clinical-operations concept linking trial sites, protocol deviations, monitoring evidence and follow-up ownership. Independent concept study by Revolvo Tech.
Independent product concept · Illustrative data
Keep a site deviation connected to its evidence.
Designed for: Clinical-operations and trial-monitoring teams. Format: Trial oversight workspace.
The problem
An oversight team needs to understand what a site reported and which evidence belongs to the follow-up. A count of open deviations cannot explain the specific discrepancy.
The direction
Trialmark brings a monitoring worklist into a selected site’s deviation record, protocol reference and follow-up responsibility.
Inside the product
Select the trial site
Site entries distinguish monitoring concerns such as a protocol deviation or safety follow-up.
Inspect the evidence
The deviation artifact lists the visit report, protocol reference and follow-up owner.
Review the deviation
Site phase, participant context and operations ownership remain visible near the review action.
Design decisions
Evidence has a reading order
The site record uses a compact table rather than a decorative analytics panel.
Give statuses a shared baseline
The evidence-header label and badge share a vertical center, while the sidebar preserves the monitoring context.
What we would validate next
Agree protocol-specific terminology, oversight responsibilities, access controls and validation requirements with the trial’s clinical-operations specialists.
This is an independent design exploration. The screens use illustrative brands and records; they describe a proposed experience.
Related concepts
Build around the way your team works.
Bring us the process, the friction and the people involved. We can define a focused first milestone for your product.
Discuss your product